Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 71

Sort by

Sort Order Select

Journal Articles

Long-term follow-up results of nonremission relapsed/refractory DLBCL with CAR T-cell cocktail therapy alone or in combination with ASCT

Xiaoying Zhang, Jue Wang, Na Wang, Jia Wei, Yang Cao, Yicheng Zhang

Blood (2025) 146 (Supplement 1): 7243.

https://doi.org/10.1182/blood-2025-7243

Published: 2025

Journal Articles

Long-term follow-up reveals sustained benefit of dual CD19/CD22 CAR T-cell therapy alone or combined with autologous stem cell transplantation in TP53-altered relapsed/refractory B-cell non-Hodgkin lymphoma

Juan Peng, Zekai Mao, Yang Cao, Na Wang, Jue Wang, Yang Yang, Jinghuan Xu, Fankai Meng, Liting Chen, Xia Mao, Jiaqi Guo, Xiaoxi Zhou, Yicheng Zhang, Jia Wei

Blood (2025) 146 (Supplement 1): 3712.

https://doi.org/10.1182/blood-2025-3712

Published: 2025

Journal Articles

Impacts of IPSS-m and conditioning intensity in allogeneic hematopoietic cell transplant for patients with myelodysplasia neoplasms

Zilu Zhang, Xiaoqian Xu, Qi Wen, Ruoxuan Zhang, Hongru Chen, Minli Hu, Chupeng Zhang, Chuanhe Jiang, Luxiang Wang, Jiayu Huang, Zengkai Pan, Hua Jin, Yanmin Zhao, Wei Shi, Xiao-Dong Mo, Yang Cao, Xiaoxia Hu

Blood (2025) 146 (Supplement 1): 1062.

https://doi.org/10.1182/blood-2025-1062

Published: 2025

Journal Articles

Different graft-vs-host disease prophylaxis strategy for allogeneic hematopoietic stem cell transplantation in adults with chronic active EBV infection

Min Liu, Qiuxia Yu, Yang Cao, Jia Wei, Yaxian Ma, Zetong Hong, Qing Yin, Yan Feng, ZhaoYang Hong, Tongjuan Li, Jia Gu, Liting Chen, Yicheng Zhang, Miao Zheng

Blood (2025) 146 (Supplement 1): 7758.

https://doi.org/10.1182/blood-2025-7758

Published: 2025

Journal Articles

Vedolizumab for steroid-refractory gastrointestinal acute graft-versus-host disease: A real-world VAST study

Le-Qing Cao, Yi Xia, Song Xue, Na Xu, Jian-Ping Zhang, Yang Cao, Yue-Wen Wang, Ze Tian, Jun Kong, Dao-Xing Deng, Xiaohui Zhang, Xiao-Dong Mo

Blood (2025) 146 (Supplement 1): 7772.

https://doi.org/10.1182/blood-2025-7772

Published: 2025

Journal Articles

Impact of induction response and co-mutations on transplant outcomes in AML with myelodysplasia-related gene mutations: A multicenter retrospective study

Xing Chen, Ruoxuan Zhang, Liang Huang, Xiaodong Mo, Xiaoxia Hu, Yang Cao

Blood (2025) 146 (Supplement 1): 3394.

https://doi.org/10.1182/blood-2025-3394

Published: 2025

Journal Articles

Oral iptacopan demonstrates efficacy as salvage therapy for high-risk transplant-associated thrombotic microangiopathy: First real-world experience

Fei Gao, Qi Wen, Jian-Ping Zhang, Yuanyuan Zhang, Na Xu, Yeqian Zhao, Jimin Shi, He Huang, Xiaofan Li, Yang Cao, Weijie Cao, Xiaodong Mo, Yanmin Zhao

Blood (2025) 146 (Supplement 1): 2431.

https://doi.org/10.1182/blood-2025-2431

Published: 2025

Journal Articles

Adult Acute Myeloid Leukemia with fus::ERG fusion: A national, retrospective, multi-center study

Xiaoxia Hu, Yunxiang Zhang, Jianfeng Li, Jingtao Huang, Shaowei Qiu, Anli Lai, Jia Chen, Xiao-Dong Mo, Huafeng Wang, Yanmin Zhao, Xiaoyu Zhu, Yang Cao, Ran Zhang, Weijie Cao, Yue Lu, Fang Zhou, Xiangqin Weng, Yongmei Zhu

Blood (2025) 146 (Supplement 1): 1698.

https://doi.org/10.1182/blood-2025-1698

Published: 2025

Journal Articles

Enhanced efficacy and safety of optimized tandem CD19/CD20 CAR T-cell Therapy in refractory/relapsed B-cell lymphoma

Jiaqi Guo, Ang Zhang, Weiwei Tian, Xiaoxi Zhou, Xiao Zhao, Yang Cao, Shaolong He, Jie Zhao, Lihong Liu, Lifang Huang, Yicheng Zhang, Bing Liu, Jia Wei

Blood (2025) 146 (Supplement 1): 2325.

https://doi.org/10.1182/blood-2025-2325

Published: 2025

Journal Articles

Distinct prognosis and transplant timing in core-binding factor Acute Myeloid Leukemia

Blood (2025) 146 (Supplement 1): 5297.

https://doi.org/10.1182/blood-2025-5297

Published: 2025

Journal Articles

Prognostic impact of transplant conditioning intensity (TCI) score and minimal identifiable disease (MID) in MDS: A multicenter trophy group study

Ruoxuan Zhang, Yang Cao, Hua Jin, Wei Shi, Xiaoxia Hu, Liang Huang

Blood (2025) 146 (Supplement 1): 4205.

https://doi.org/10.1182/blood-2025-4205

Published: 2025

Journal Articles

Changing Donor Was Critical for the Successful Salvage Second Transplantation for Graft Failure after the First Allogeneic Stem Cell Transplantation: A Chinese Multicenter Retrospective Study

Blood (2024) 144 (Supplement 1): 2109.

https://doi.org/10.1182/blood-2024-205561

Published: 2024

Journal Articles

Superiority in the Longer Duration of Response and Better Central Nervous System Penetration of CAR-T Cell Therapy over Blinatumomab Infusion for Relapsed/ Refractory B-Cell Acute Lymphoblastic Leukemia: A Retrospective Single-Center Analysis

Yuhang Cheng, Xueyan Sun, Meijuan Huang, Lei Zhao, Jue Wang, Hanyu Wang, Wanying Liu, Shanwei Ye, Liang Huang, Gaoxiang Wang, Yang Cao

Blood (2024) 144 (Supplement 1): 1447.

https://doi.org/10.1182/blood-2024-207442

Published: 2024

Journal Articles

Type I Interferon Impairs the Function of CAR-T Cells By Disrupting Immune Synapse Assembly

Meijuan Huang, Lei Zhao, Yuhang Cheng, Liang Huang, Jianfeng Zhou, Dengju Li, Jue Wang, Yang Cao

Blood (2024) 144 (Supplement 1): 3407.

https://doi.org/10.1182/blood-2024-197968

Published: 2024

Journal Articles

A Phase 2 Clinical Trial of Anti-CD19 CAR-T (pCAR-19B) in Chinese Pediatric and Young Adult with Relapsed/Refractory (R/R) CD19+ B-ALL: The First Pivotal Study in an Asian Population

Blood (2024) 144 (Supplement 1): 4205.

https://doi.org/10.1182/blood-2024-206408

Published: 2024

Journal Articles

Impact of Febrile Neutropenia on Mobilization Efficacy in Multiple Myeloma Patients and Post-Transplant Infection Risk in Lymphoma Patients: Insights from Real-World Multicenter Data

Hu Qian, Xinwei Wang, Liping Yang, Juan Peng, Jie Zhao, Shaolong He, Jin Zhao, Jiaqi Guo, Yuekun Fang, Fankai Meng, Yang Cao, Lifang Huang, Junni Wei, Liangming Ma, Li-Ping Su, Weiwei Tian, Yicheng Zhang, Jia Wei

Blood (2024) 144 (Supplement 1): 7834.

https://doi.org/10.1182/blood-2024-205222

Published: 2024

Journal Articles

Epstein-Barr Virus Reactivation and Post-Transplant Lymphoproliferative Disorders after Allo-HSCT in the Era of Letermovir for Cytomegalovirus Prophylaxis

Jingtao Huang, Jing Zhou, Shixuan Zhang, Ruoxuan Zhang, Zengkai Pan, Luxiang Wang, Chuanhe Jiang, Jiayu Huang, Zilu Zhang, Yanmin Zhao, Yang Cao, Jianmin Wang, Xiaoxia Hu

Blood (2024) 144 (Supplement 1): 268.

https://doi.org/10.1182/blood-2024-202762

Published: 2024

Journal Articles

Tandem CD19/20 CAR-T Showed Durable Efficacy in Patients with Relapsed/Refractory B-Cell Lymphoma: Interim Results from a Multicenter Phase I/II Trial

Jia Wei, Xiaoxi Zhou, Hui Luo, Yang Cao, Jiaqi Guo, Jie Zhao, Lifang Huang, Ang Zhang, Lihong Liu, Weiwei Tian, Yicheng Zhang

Blood (2024) 144 (Supplement 1): 3132.

https://doi.org/10.1182/blood-2024-205207

Published: 2024

Journal Articles

Establishment of a Novel Waldenström's Macroglobulinemia (WM) Cell Line Bcwm.2 with Del6q and Unique MYD88 S243N , LYN I297N , SPI1 Q227E Mutations and That Shows Robust In Vivo Engraftment in SCID NOD Mice

Shirong Liu, Xia Liu, Choudhury Fabliha Binte Yusuf, Amanda Kofides, Kara M Soroko, Johany Penailillo, Alexa G Canning, Yang Cao, Guang Yang, Lian Xu, Nickolas Tsakmaklis, Maria Luisa Guerrera, Christopher J Patterson, Ruben D. Carrasco, Prafulla C. Gokhale, Shayna R Sarosiek, Jorge J. Castillo, Zachary R Hunter, Steven P. Treon

Blood (2024) 144 (Supplement 1): 5834.

https://doi.org/10.1182/blood-2024-211381

Published: 2024

Journal Articles

Improving CAR-T Cell Function through a Targeted Cytokine Delivery System Utilizing CAR Target-Modified Extracellular Vesicles

Yuanyuan Zhang, Meijuan Huang, Tianjiao Liu, Yuhang Cheng, Dengju Li, Yang Cao, Wei Mu, Liting Chen, Li Zhu, Tongjuan Li, Liang Huang, Jia Wei, Lei Zhao, Jue Wang

Blood (2024) 144 (Supplement 1): 3419.

https://doi.org/10.1182/blood-2024-206731

Published: 2024

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Long-term follow-up results of nonremission relapsed/refractory DLBCL with CAR T-cell cocktail therapy alone or in combination with ASCT

Long-term follow-up reveals sustained benefit of dual CD19/CD22 CAR T-cell therapy alone or combined with autologous stem cell transplantation in TP53-altered relapsed/refractory B-cell non-Hodgkin lymphoma

Impacts of IPSS-m and conditioning intensity in allogeneic hematopoietic cell transplant for patients with myelodysplasia neoplasms

Different graft-vs-host disease prophylaxis strategy for allogeneic hematopoietic stem cell transplantation in adults with chronic active EBV infection

Vedolizumab for steroid-refractory gastrointestinal acute graft-versus-host disease: A real-world VAST study

Impact of induction response and co-mutations on transplant outcomes in AML with myelodysplasia-related gene mutations: A multicenter retrospective study

Oral iptacopan demonstrates efficacy as salvage therapy for high-risk transplant-associated thrombotic microangiopathy: First real-world experience

Adult Acute Myeloid Leukemia with fus::ERG fusion: A national, retrospective, multi-center study

Enhanced efficacy and safety of optimized tandem CD19/CD20 CAR T-cell Therapy in refractory/relapsed B-cell lymphoma

Distinct prognosis and transplant timing in core-binding factor Acute Myeloid Leukemia

Prognostic impact of transplant conditioning intensity (TCI) score and minimal identifiable disease (MID) in MDS: A multicenter trophy group study

Changing Donor Was Critical for the Successful Salvage Second Transplantation for Graft Failure after the First Allogeneic Stem Cell Transplantation: A Chinese Multicenter Retrospective Study

Superiority in the Longer Duration of Response and Better Central Nervous System Penetration of CAR-T Cell Therapy over Blinatumomab Infusion for Relapsed/ Refractory B-Cell Acute Lymphoblastic Leukemia: A Retrospective Single-Center Analysis

Type I Interferon Impairs the Function of CAR-T Cells By Disrupting Immune Synapse Assembly

A Phase 2 Clinical Trial of Anti-CD19 CAR-T (pCAR-19B) in Chinese Pediatric and Young Adult with Relapsed/Refractory (R/R) CD19+ B-ALL: The First Pivotal Study in an Asian Population

Impact of Febrile Neutropenia on Mobilization Efficacy in Multiple Myeloma Patients and Post-Transplant Infection Risk in Lymphoma Patients: Insights from Real-World Multicenter Data

Epstein-Barr Virus Reactivation and Post-Transplant Lymphoproliferative Disorders after Allo-HSCT in the Era of Letermovir for Cytomegalovirus Prophylaxis

Tandem CD19/20 CAR-T Showed Durable Efficacy in Patients with Relapsed/Refractory B-Cell Lymphoma: Interim Results from a Multicenter Phase I/II Trial

Establishment of a Novel Waldenström's Macroglobulinemia (WM) Cell Line Bcwm.2 with Del6q and Unique MYD88 S243N , LYN I297N , SPI1 Q227E Mutations and That Shows Robust In Vivo Engraftment in SCID NOD Mice

Improving CAR-T Cell Function through a Targeted Cytokine Delivery System Utilizing CAR Target-Modified Extracellular Vesicles

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only